ライフサイエンスコーパス: discomfort

1 e clinical symptom measures (e.g., abdominal discomfort).

2 isrupted agriculture and caused severe human discomfort.

3 s, use of 32-gauge needles may minimize this discomfort.

4 reatments were well tolerated with only mild discomfort.

5 blurred vision, allergic-type reactions, and discomfort.

6 rms, fear, anxiety, embarrassment, pain, and discomfort.

7 as well as for Mobility, Self-care, and Pain/Discomfort.

8 nscontinental flight--may trigger intestinal discomfort.

9 Migraine symptoms often include auditory discomfort.

10 ecause of significant gastrointestinal tract discomfort.

11 ganda, when participants experienced vaginal discomfort.

12 also present less frequently with chest pain/discomfort.

13 ecal calprotectin in patients with abdominal discomfort.

14 n resulted (paradoxically) in greater visual discomfort.

15 tress recovery, disability glare, and visual discomfort.

16 plans for future mammography on the basis of discomfort.

17 es in body core temperature and/or perceived discomfort.

18 uires deep sedation to prevent shivering and discomfort.

19 st cases, patients reported no postoperative discomfort.

20 and from participants' emotional or physical discomfort.

21 ed in reach and caused patients considerable discomfort.

22 , prolonged recovery, shivering, and thermal discomfort.

23 arned to associate with inflammation-induced discomfort.

24 and into which intrusion by others can cause discomfort.

25 ation causes malaise and general feelings of discomfort.

26 The most frequent AE was mild abdominal discomfort.

27 FI, as well as full resolution of abdominal discomfort.

28 to patients with noncardiac causes of chest discomfort (0.2%), and lower than T2MI2007 (3.6%) and ty

29 hinorrhoea 15 [10%] vs eight [5%], and nasal discomfort 15 [10%] vs one [<1%]).

30 to anxiety (8% vs. 25%; P = 0.029), general discomfort (18% vs. 42%; P = 0.010), hunger (44% vs. 67%

31 reporting glare (48.1% [78 of 162]), pain or discomfort (26.5% [43 of 162]), and redness (24.7% [40 o

32 gue (5.4 +/- 3.8 vs 3.0 +/- 2.7, P = .0003), discomfort (3.9 +/- 4.6 vs 1.8 +/- 2.2, P = .004), and i

33 gency department with bilateral red eyes and discomfort 36 hours after she received her bimonthly dos

34 ivity to swallowing cold items (71%), throat discomfort (63%), or muscle cramps (42%).

35 odds ratio, 3.9 [1.8-8.2]; p < 0.001), pain/discomfort (68% vs 47%; odds ratio, 2.0 [1.1-3.8]; p = 0

36 nol 270 group patients experienced less heat discomfort (72% vs 86%, respectively; P < .001), no diff

37 t experience (including satisfaction, worry, discomfort, adverse effects) and a 3-month questionnaire

38 endpoints were to assess effects on patient discomfort, adverse events, and clinical outcomes.

39 ity was assessed based on subject reports of discomfort after drop instillation.

40 Reported discomfort after intracoronary application was significa

41 nts to triage patients presenting with chest discomfort after PCI.

42 We asked about pain or discomfort after staining and evaluated the cornea at th

43 enting or controlling postoperative pain and discomfort after surgical implant placement.

44 One patient stated slight discomfort after the procedure; this however, resolved i

45 to have reported more satisfaction and less discomfort after treatment.

46 e propose cytokine release as a cause of the discomfort and a central mechanism through glial cell up

47 improved other abdominal symptoms, including discomfort and bloating, and global measures of IBS-C co

48 y, test patients reported significantly less discomfort and CFH (P </= 0.02) and took a significantly

49 erspectives on organ donation; and physician discomfort and community misunderstanding of the process

50 therapy, they are not effective in improving discomfort and corneal epithelial disease in all patient

51 should be weighed against potential patient discomfort and cost escalation.

52 europhysiological research is clarifying how discomfort and dazzling glare depend on different retina

53 Falls are common health events that cause discomfort and disability for older adults and stress fo

54 suggest that the MP carotenoids reduce glare discomfort and disability, shorten photostress recovery

55 A 10-L paracentesis improved abdominal discomfort and disclosed a transudate, suggestive of por

56 ine staining and improved symptoms of ocular discomfort and eye dryness compared with placebo when ad

57 veloped patient education videos about chest discomfort and heart failure.

58 with lower CT blood flow had more abdominal discomfort and immunoglobulin A-antilipopolysaccharide (

59 s AEs in 4 subjects and 2 serious AEs [chest discomfort and increased heart rate, without cardiac sym

60 d cost of these procedures, besides patients discomfort and increased risks, highlights the need to d

61 After that she felt discomfort and itching in her oral cavity.

62 this relationship between localized physical discomfort and its more global consequences, we investig

63 iagnosis experience themes included physical discomfort and limited functionality, presence of comorb

64 vents (most commonly musculoskeletal pain or discomfort and mild hypoglycemia) in the lifestyle group

65 an effectively relieve or markedly attenuate discomfort and pain, revealing the importance of ongoing

66 red to Er:YAG in terms of less postoperative discomfort and pain.

67 criteria at patient satisfaction level were discomfort and paresthesia, satisfaction with appearance

68 eadmission is associated with low-risk chest discomfort and patient anxiety.

69 Thresholds for discomfort and perception cumulative scores were measure

70 s occur frequently and may also cause severe discomfort and poor quality of life.

71 tection of LA/LAA thrombi/clot, avoiding the discomfort and risks associated with TEE.

72 nnaires with visual analog scales to measure discomfort and satisfaction.

73 Domains included pain/discomfort and sedation-agitation behaviors; sedative, a

74 ne eye open as long as possible, and overall discomfort and sensations associated with tear break-up

75 acceptability, which included needle-related discomfort and temporary worsening of symptoms, pressure

76 Attention to a patient's discomfort and transportation limitations requires hypof

77 action of the tooth to relieve the patient's discomfort and treating the adjacent teeth with periodon

78 with decreased scores in dimensions of pain/discomfort and usual activity, respectively.

79 DED, frequently associated with symptoms of discomfort and visual disturbance, also impairs quality

80 he congruency between bodily action (comfort/discomfort) and target emotion (happiness/anger) valence

81 cular symptoms (pain, light sensitivity, and discomfort), and in 95% for dryness.

82 e ascertainment, 12% (29 of 247) experienced discomfort, and 2% (6 of 247) sustained injuries likely

83 care, 47% for usual activities, 50% for pain/discomfort, and 41% for anxiety/depression.

84 Heart rate, arrhythmia, patient discomfort, and adverse events also were monitored.

85 BMs, stool consistency, straining, abdominal discomfort, and bloating.

86 itivity around the wound area, postoperative discomfort, and changes in feeding habits (CFH).

87 Patient-subjective outcomes, such as pain, discomfort, and complications, and financial aspects and

88 Patient-reported pain, discomfort, and esthetic satisfaction were also recorded

89 the patient's body causes nausea, vomiting, discomfort, and even gastric mucous damage.

90 oblems such as tissue irritation, abscesses, discomfort, and inconvenience.

91 chloride (LiCl), a salt that creates gastric discomfort, and lipopolysaccharide (LPS), a bacterial ce

92 ement for symptoms of blurry vision, pain or discomfort, and redness.

93 Varicocele grade, duration of discomfort, and the quality of pain tended to predict ou

94 by altered bowel habits, persistent pain and discomfort, and typically colorectal hypersensitivity.

95 level, gingival index, plaque index, patient discomfort, and wound healing index were recorded before

96 orticosteroid therapy, for treating pain and discomfort, are not associated with worse outcomes when

97 erly people and, when severe, causes as much discomfort as chronic pain.

98 cause the helmet-type mask caused no pain or discomfort, as compared to the face mask.

99 Discomfort associated with bowel preparation was higher

100 ability to monitor and skillfully cope with discomfort associated with craving or negative affect, t

101 oring systems that eliminate risks, cost and discomfort associated with surgical extraction.

102 tions (VAS score >30 for pain/numbness/groin discomfort) at 12 months after surgery.

103 tive culinary image as well as to intestinal discomfort attributable to the oligosaccharide content o

104 ir infectious keratitis and noted no pain or discomfort attributed to the topical therapy.

105 nal diarrhea, FI, and postprandial abdominal discomfort before administration of SBI.

106 Seven attributes were assessed: pain or discomfort before and during testing, fear or anxiety be

107 nge, birth weight >3600 g, absence of nipple discomfort between 0-3 d postpartum, and infant failing

108 There were significant differences in discomfort between different combinations of technologis

109 SBM, stool consistency, straining, abdominal discomfort, bloating, global assessments, and quality of

110 variance and these were termed: 'oesophageal discomfort', 'bowel dysfunction', 'abdominal discomfort'

111 ortant symptoms, such as palpitations, chest discomfort, breathlessness, anxiety, and syncope, which

112 ler hollow-bore needles may decrease patient discomfort, but current evidence is equivocal.

113 Iodixanol 270 was associated with less heat discomfort, but did not affect heart rate differently co

114 hreshold cold thermoreceptors signaling cold discomfort, but it also transforms a subpopulation of po

115 n was associated with a reduction of patient discomfort by 18.5% [95% confidence interval (CI), 10.7-

116 n was associated with a reduction of patient discomfort by 18.5% [95% confidence interval (CI), 10.7-

117 and reduces the rate of pain/numbness/groin discomfort by 45% relative to sutures without increasing

118 turn contribute to negative attitudes and/or discomfort by healthcare professionals.

119 management of telaprevir skin rash and anal discomfort by switching to boceprevir.

120 cidence of postoperative pain/numbness/groin discomfort by up to 50% compared with sutures for repair

121 ncidence, severity, and duration of pain and discomfort caused by HZ.

122 stridor and show prolonged coughs and chest discomfort caused by small-airways dysfunction have incr

123 PaO2/FiO2SET, patient discomfort caused by the interface and by symptoms of ai

124 ncreasing but still relatively low passenger discomfort, cumulative trip length can be cut by 40% or

125 00 consecutive eyes were reviewed for visual discomfort despite a best-corrected visual acuity (BCVA)

126 ts with incipient cataract may report visual discomfort, despite minor lens opacity on slit-lamp exam

127 (-17.3 to -7.5; p<0.0001), and in the bodily discomfort domain was -7.5 (-12.6 to -2.4; p=0.004).

128 ession (GR) might be associated with patient discomfort due to cervical dentin hypersensitivity (CDH)

129 f the individuals (76%) did not report major discomfort due to the short procedure time (max 15 min)

130 Ultrasound-guidance may reduce discomfort during axillary block placement compared with

131 ns causally associated with ongoing physical discomfort during chronic pain, or becomes independent o

132 Patients experienced more physical discomfort during colonoscopy (median, 4; interquartile

133 dication well, with only transient localized discomfort during injection.

134 Remote IPC reduces ischemic chest discomfort during PCI, attenuates procedure-related cTnI

135 oup differences in throat, chest, or overall discomfort during placement.

136 for appointment and on gastroscopy day, and discomfort during procedure accounted for over 90% of un

137 Waiting times and discomfort during procedure were main causes for patient

138 with 4% lidocaine gel significantly reduced discomfort during screening mammography, and reduced dis

139 (EST1 = .32 and EST2 = .62; P = .001), less discomfort during sex (EST1 = .49 and EST2 = .66; P = .0

140 osmolarity may cause the gradual increase in discomfort during slow tear film thinning, whereas the s

141 ilm thinning, whereas the sharp increases in discomfort during TBU suggest a more complex stimulus.

142 Visual discomfort during the glare presentation was assessed wi

143 Each patient reported little to no discomfort during the procedure.

144 R group than in the iFR group reported chest discomfort during the procedure.

145 26).The primary outcome was patient-reported discomfort during transvaginal ultrasound examinations p

146 26).The primary outcome was patient-reported discomfort during transvaginal ultrasound examinations p

147 The rate of increasing discomfort during trials was highly correlated with the

148 lethargy, flank pain, hematuria, suprapubic discomfort, dysuria, and urgent or frequent urination.

149 failed examinations, 25 (35.7%) were due to discomfort; eight (11.4%), to head motion; two (2.9%), t

150 thought characterized by repetitive focus on discomforting emotions or stimuli.

151 chest pain were included in the oesophageal discomfort factor.

152 n presented with various symptoms like chest discomfort, fatigue, dizziness, atrial fibrillation, and

153 es chronic muscle shortening associated with discomfort, fatigue, reduced shock absorption, and incre

154 est that pelvic examinations may cause pain, discomfort, fear, anxiety, or embarrassment in about 30%

155 In patients with abdominal discomfort, fecal calprotectin is a useful non-invasive

156 This result was achieved with only minimal discomfort felt by the patients.

157 less postoperative inflammation and patient discomfort for 1 to 3 weeks after strabismus surgery for

158 criteria, with symptoms of abdominal pain or discomfort for at least 2 days/wk) and reported bloating

159 of diarrhea and absence of severe abdominal discomfort for more than 2 consecutive days including da

160 reased longevity can save costs and minimize discomfort for patients.

161 ges are combined with lower invasiveness and discomfort for patients.

162 differences of VAS scores for perception of discomfort for periodontal surgery (9.9 +/- 17.0) compar

163 the failure of implanted medical devices and discomfort for the recipient.

164 The patient reported upper abdominal discomfort for two months; nausea, vomiting or weight lo

165 are well accepted, but further reducing the discomfort from bowel preparation may increase CT colono

166 Discomfort glare is caused by situational illumination t

167 subscores for questions emphasizing fatigue, discomfort, impaired vision, and cognitive performance w

168 y efficacy end point, relief of IBS pain and discomfort, improved significantly in patients given 100

169 Symptoms were ocular surface discomfort in 10 patients (45%), reduced vision in 4 pat

170 ence of true IBS was lower abdominal pain or discomfort in association with a change in bowel habit a

171 ar-old woman with PD experienced a disabling discomfort in her pelvis and genital region for 3 years.

172 Symptomatic UTI causes significant discomfort in infected patients, results in lost product

173 garding the mechanisms behind ocular surface discomfort in patients with tear film disturbances.

174 hout electrode corrosion and burning/causing discomfort in subjects.

175 es found that antimicrobials reduce pain and discomfort in the acute phase of illness compared with p

176 ymptoms of diarrhea, abdominal bloating, and discomfort in the midepigastrium.

177 ared to sham-OA rats and may reflect ongoing discomfort in the OA animal.

178 ts occurred apart from mild gastrointestinal discomfort in two patients, which disappeared when liqui

179 Primary objective was assessment of patient discomfort including acceptance of the gag reflex during

180 The risk of reporting problems with pain or discomfort increased from 24- to 36-months postinjury (A

181 The evaluation of patients with abdominal discomfort is challenging and patient selection for endo

182 underlying conditions associated with ocular discomfort is essential to better understand the mechani

183 benefits of sharing and individual passenger discomfort is lacking.

184 n as long as possible (MBI), indicated their discomfort level continuously, and rated ocular sensatio

185 The patient discomfort level during the first postoperative day was

186 al Quality Analysis System measurements, and discomfort level in each group.

187 Pterygium recurrence, patient discomfort level, and surgery time were reduced markedly

188 ired 800 to 900 mOsM/kg to generate the same discomfort levels reported during tear break-up.

189 s with screening, but some women experienced discomfort, loss of privacy, emotional distress, and con

190 ntestinal endoscopy (UGE) can induce patient discomfort, mainly due to a strong gag reflex.

191 rt during screening mammography, and reduced discomfort may improve the likelihood of future mammogra

192 = .007); they also experienced more physical discomfort (median score of 39 [IQR, 29-51] vs 35 [IQR,

193 ore respondents with FM reported more severe discomfort, more problems, and greater limitations relat

194 (three of whom discontinued the study): ear discomfort (n=6; three in the PENFS group, three in the

195 However due to the discomforting nature of the larger-diameter acupuncture

196 come expectation) and psychological/physical discomfort (negative outcome expectation).

197 s among lifitegrast-treated subjects: ocular discomfort (nominal P = 0.0005) and eye discomfort (nomi

198 ular discomfort (nominal P = 0.0005) and eye discomfort (nominal, P < 0.0001).

199 Ocular discomfort occurred in 43 of 49 patients in the fluorour

200 independently associated with more frequent discomfort [odds ratio (OR) = 1.9, confidence interval (

201 e replacement (TAVR) without the hazards and discomfort of transthoracic (transapical or transaortic)

202 8 analysis and Mobility, Self-care, and Pain/Discomfort on EQ5D analysis.

203 FFR value, the time to reach FFR and patient discomfort (on a subjective scale from 0 for no symptoms

204 sessments for "pain," "numbness," and "groin discomfort" on a scale of 0 = best and 100 = worst outco

205 Filters that decrease daytime discomfort or dazzling glare also reduce nighttime mesop

206 women of reproductive age have some physical discomfort or dysphoria in the weeks before menstruation

207 Natural products that elicit discomfort or pain represent invaluable tools for probin

208 testinal disorder characterized by abdominal discomfort or pain that is accompanied by a disturbance

209 n occur in the form of constant or recurrent discomfort or pain.

210 rized by upper abdominal symptoms, including discomfort or postprandial fullness.

211 essure on the surrounding organs that causes discomfort, or insert openings between tissues.

212 No patients reported pain, discomfort, or other symptoms, and no complications were

213 .041), usual activities (p < 0.001) and pain/discomfort (p < 0.001).

214 ment: physical pain (P = 0.002), psychologic discomfort (P <0.001), psychologic disability (P = 0.003

215 lis; P <0.05) up to 3 days after surgery and discomfort (P <0.05) up to 2 days after surgery compared

216 sholds (average P < 0.004), and lower visual discomfort (P = 0.002).

217 body sensation (nominal P = 0.0418), and eye discomfort (P = 0.0048) versus participants receiving pl

218 1) physical pain (P = 0.003); 2) psychologic discomfort (P = 0.008); 3) physical disability (P = 0.03

219 tiety (P = 0.043), gastrointestinal pain and discomfort (P = 0.01), altered taste (P= 0.006), and dia

220 provements were observed at day 84 in ocular discomfort (P = 0.0273) and eye dryness (P = 0.0291), th

221 o received remote IPC experienced less chest discomfort (P=0.0006) and ECG ST-segment deviation (P=0.

222 terized by altered sensory qualities, namely discomfort/pain and colorectal hypersensitivity.

223 discomfort', 'bowel dysfunction', 'abdominal discomfort', 'pelvic floor dysfunction', and 'self-induc

224 inging, itching, foreign body sensation, eye discomfort, photophobia, pain), ocular discomfort score

225 r higher are more likely to have more ocular discomfort postoperatively.

226 tent instillation site symptoms (irritation, discomfort) primarily on the initial lifitegrast dose at

227 in 17 patients (68%), causing tenderness or discomfort, pruritus, sensitivity to touch, and/or disco

228 Total OHIP-14 score and psychologic discomfort, psychologic disability, social disability, a

229 of patients on average and included tearing, discomfort, pyogenic granuloma, and dacryocystitis.

230 , but this comes at the expense of passenger discomfort quantifiable in terms of a longer travel time

231 reporting pelvic examination-related pain or discomfort ranged from 11% to 60% (median, 35%; 8 studie

232 Tear instability led to an average discomfort rating of 6.13 and sensations of burning and

233 lare presentation was assessed with a visual discomfort rating scale.

234 significantly correlated with higher visual discomfort ratings (P = 0.037).

235 Handgrip strength test results and discomfort ratings did not differ across AT groups.

236 strength of the hand and forearm muscles and discomfort ratings.

237 esented to the emergency room with abdominal discomfort, rectal pain, and blood-tinged stools.

238 He had generalized muscle weakness, facial discomfort, recurrent episodes of carpopedal spasms and

239 ed by transient hypoxemia, bleeding, patient discomfort, reexpansion pulmonary edema, and pneumothora

240 udy, 575 consecutive patients with abdominal discomfort referred for endoscopy to the Department of G

241 Discomfort related both to the interface and to airways

242 isorder, and approximately 77% reported some discomfort related to computer use.

243 s an unpleasant sensation including pain and discomfort related to the urinary bladder, without infec

244 7-5.6; P<0.001) but did not predict a higher discomfort-related subscore (beta, 1.1 point; P = 0.07).

245 ions about vision and task performance), and discomfort-related subscore (derived from questions abou

246 d with higher total OSDI score or vision- or discomfort-related subscore (P>0.20 for all).

247 Ocular discomfort-related subscores, however, were similar in b

248 mechanotransmission and possibly non-evoked discomfort, respectively.

249 e change, from baseline to day 84, in ocular discomfort score (0-4 scale) in study eye, eye discomfor

250 , eye discomfort, photophobia, pain), ocular discomfort score (ODS), and safety/tolerability of lifit

251 scomfort score (0-4 scale) in study eye, eye discomfort score (VAS), total corneal staining score in

252 SDI], 7-item visual analog scale, and ocular discomfort score [Ora scale]) measures were assessed at

253 Overall discomfort score was less in WC than in SC patients (26

254 The highest (mean [95% confidence interval]) discomfort scores were reported in the Reflux (heartburn

255 of the 2 treatments were similar, with mild discomfort seen in the majority of patients in both grou

256 same subjects used the same scales to report discomfort sensations after instillation of NaCl and suc

257 The L-group assessed the discomfort significantly lower on a visual analog scale

258 me because of the psychological distress and discomfort such misdeeds cause.

259 was highly correlated with increasing ocular discomfort, suggesting that both tear film thinning and

260 y women discontinued tube feeding because of discomfort, suggesting that it is poorly tolerated as an

261 anied with nasal discharge, sneezing, throat discomfort, swelling of the uvula.

262 significantly lower visceral thresholds for discomfort than mild IBS patients and severe IBS patient

263 Partial PPI responders reported more discomfort than treatment-naive patients in the Reflux,

264 lled Gabriotto, including a portrayal of the discomfort that the protagonist experienced and a rudime

265 t group reported non-serious therapy-related discomfort that was resolved with simple system reprogra

266 ymptoms in the genital region, such as pain, discomfort, tingling, and burning sensations, have rarel

267 ornea range in severity from minor transient discomfort to the blinding disease herpes stromal kerati

268 , spreading and that they cause little to no discomfort to the patient.

269 t infections (UTIs) inflict extreme pain and discomfort to those affected and have profound medical a

270 report a patient with PD and severe genital discomfort unrelated to motor fluctuations but compatibl

271 Duration of surgery, level of patient discomfort, visual acuity (VA), surgically induced refra

272 Patient discomfort was assessed by using a visual analog scale (

273 taining to satisfaction, worry, and physical discomfort was canvassed after both PET/CT colonography

274 rating scale and a visual analog scale, and discomfort was evaluated using a four-point verbal ratin

275 Finally, discomfort was measured by visual analog scale.

276 Injection site discomfort was more frequent in groups given vaccines wi

277 mplications, pain, recurrences, and patients discomfort was recorded on days 1, 7, 30, and 1 year aft

278 Mild discomfort was reported by 88 (21%) and mild superficial

279 Discomfort was significantly lower in the lidocaine gel

280 night sweats, itching, bone pain, abdominal discomfort, weight loss, and fevers.

281 Transient photophobia and discomfort were common.

282 Recent vomiting and abdominal discomfort were due to a high-grade stenosis in the tran

283 Rates of catheter-related discomfort were higher in the nitrofural group than they

284 imonidine, whereas blurred vision and ocular discomfort were slightly more common with BBFC than with

285 tems most likely to account for problems and discomfort were the chair, keyboard, mouse, and monitor.

286 (derived from questions about ocular surface discomfort) were calculated for each subject.

287 cale from 0 for no symptoms to 5 for maximal discomfort) were recorded for each measurement.

288 ied, such as diarrhoea (70%), fatigue (63%), discomfort when eating (81%), reflux (63%), eating restr

289 and mutual pretence to alleviate feelings of discomfort when engaged in aspects of care and caring.

290 affect the ocular surface and elicit ocular discomfort when preserved with benzalkonium chloride (BA

291 Vertigo was most discomforting when head pitch was around 60 deg extensio

292 sedation to allay anxiety and perceptions of discomfort, which may account for longer surgical times.

293 n attempt to minimise skeletal stress and/or discomfort, while a shorter stride length and time, toge

294 This may reflect discomfort with a "one size fits all" policy that makes

295 fort, pruritus, sensitivity to touch, and/or discomfort with breastfeeding.

296 Primary outcome was overall discomfort with pH-metry.

297 en aged 32-89 years who expected substantial discomfort with screening mammography were randomly divi

298 patients who had prolonged coughs and chest discomfort with the middle or high dose of ICS/LABA comb

299 Discomfort with these conclusions has in the past discou

300 oning anesthesia until the patient evidences discomfort would never be tolerated.